HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Immunity Spray Touts US Consumers’ Immunity Health Focus; Category Sales Jump On Amazon

Executive Summary

In a 2,474-person survey conducted for the TheraBreath oral care brand, 40% said they began taking immunity supplements due to the pandemic and 65% named vitamin C as the nutrient most beneficial. Immunity supplement sales on Amazon.com, meanwhile, increased 165% in 2020 to $623m.

You may also be interested in...



As Sustainability Concerns Grow, Plant-Based Gummy Gelling Agents Gaining On Gelatins

Gelatin remains most common gelling agent for gummies, plant-based agents pectin and carrageenan are gaining ground as consumers’ sustainability concerns increase. Dupont Nutrition & Biosciences scientist says pectin and carrageenan have added benefits of higher melting points and lower costs.

Kyowa Hakko Expands Probiotic Supplies With ‘Dead’ Ingredient To Battle Eye Fatigue

Kyowa Hakko unveils supplement ingredient Eyemuse, a heat-treated “parabiotic” found to reduce eye fatigue, filter blue light and support a balanced immune response. CRN campaign educates retailers, consumers about probiotics and helps retailers improve handling of the products.

No Pandemic Hangover Expected For Health, Beauty Launches At Independent Pharmacies

Wellness products accounted for the highest number of launches among health, wellness and beauty products at independent pharmacies in 2020. But the overall number slumped 21.1% due to the pandemic, according to Hamacher Resource Group’s report on a product rating system.

Topics

UsernamePublicRestriction

Register

RS151183

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel